Belongs to

• Center for Hematologic Malignancies

Types of Work

["2016"]

[[["Journal Articles",1326],["Meeting Abstracts",952],["Reviews",30],["Book Sections",29],["Conference Papers",15],["Editorials",9],["Research Letters",8],["Correspondences",2],["Guidelines",2],["Books Whole",1]]]

[2374]

Popular keywords

• animals
• article
• controlled study
• human
• human cell
• humans
• mouse
• nonhuman
• priority journal
• unclassified drug

Recent Works

1. Phase I study of the CD47 blocker TTI-621 in patients with relapsed or refractory hematologic malignancies

   Journal Article

   Ansell, S. M.; Maris, M. B.; Lesokhin, A. M.; Chen, R. W.; Flinn, I. W.; Sawas, A.; Minden, M. D.; Villa, D.; Percival, M. E. M.; Advani, A. S.; more...
   Clinical Cancer Research (2021)

   Fulltext@MSK | Save
2. Engineered cells as a test platform for radiohaptens in pretargeted imaging and radioimmunotherapy applications

   Journal Article

   Dacek, M. M.; Veach, D. R.; Cheal, S. M.; Carter, L. M.; McDevitt, M. R.; Punzalan, B.; Burnes Vargas, D.; Kubik, T. Z.; Monette, S.; Santich, B. H.; more...
   Bioconjugate Chemistry (2021)

   Fulltext@MSK | Save
3. Cytotoxic lymphocytes target characteristic biophysical vulnerabilities in cancer

   Journal Article

   Tello-Lafoz, M.; Srpan, K.; Sanchez, E. E.; Hu, J.; Remsik, J.; Romin, Y.; Calò, A.; Hoen, D.; Bhanot, U.; Morris, L.; more...
   Immunity (2021)

   Fulltext@MSK | Save